Schafroth U, Godang K, Ueland T, Berg J P, Bollerslev J
Department of Endocrinology, National University Hospital, Oslo, Norway.
J Endocrinol Invest. 2000 Jun;23(6):349-55. doi: 10.1007/BF03343737.
Cushing's syndrome (CS) is associated with weight gain and visceral obesity. We examined the relationship between regional fat distribution and serum levels of leptin, cortisol and insulin. Twenty-three consecutive patients with recently diagnosed CS (18 with pituitary adenoma, 5 with adrenal tumor), where compared to obese controls, matched for age, sex and Body Mass Index (BMI). Serum insulin, leptin, cortisol, C-peptide and body composition determined by DEXA were measured. Serum leptin levels were significantly increased in patients with CS (36.9+/-3.8 vs 18.9+/-2.4 ng/ml, p<0.001; women: 40.1+/-4.6 vs 21.7+/-2.9 ng/ml, p<0.01; men: 27.9+/-5.7 vs 10.9+/-2.3 ng/ml; p<0.05), the same were fasting insulin levels (178+/-30 vs 81+/-10 pmol/l; p<0.01) and C-peptide (1.51+/-0.12 vs 0.77+/-0.07 nmol/l; p<0.001). In a subgroup of 12 patients, truncal fat mass was significantly elevated when compared to obese controls (19.2 kg vs 14.7 kg, p<0.01, and 42% vs 36% in percentage of truncal body tissue, p<0.05), whereas total fat mass was insignificantly increased. Serum leptin correlated positively to total body fat (%) as in patients with CS (r=0.94, p<0.001) as in controls (r=0.68, p<0.01). The correlation to truncal body fat (%) was also significant in both groups (CS: r=0.84, p<0.001; controls: r=0.63, p<0.01). Multiple regression showed that percent total body fat was the predictor of leptin concentrations among patients with CS (r2=0.88, p<0.001) whereas insulin did not contribute significantly to the variance in leptin concentrations. In controls, both leptin and insulin (r2=0.65, p<0.001) contributed significantly to the variations in leptin levels. Controlled for the differences in total body fat, patients with endogenous CS have significantly increased serum leptin levels, compared to BMI-matched obese controls. This suggests that hyperleptinemia in CS not primarily reflects changes in body composition, but is the result of different hormonal influences on adipose tissue.
库欣综合征(CS)与体重增加和内脏肥胖有关。我们研究了局部脂肪分布与瘦素、皮质醇和胰岛素血清水平之间的关系。连续纳入23例近期诊断为CS的患者(18例垂体腺瘤患者,5例肾上腺肿瘤患者),并与年龄、性别和体重指数(BMI)相匹配的肥胖对照组进行比较。检测血清胰岛素、瘦素、皮质醇、C肽水平以及通过双能X线吸收法(DEXA)测定身体成分。CS患者的血清瘦素水平显著升高(36.9±3.8 vs 18.9±2.4 ng/ml,p<0.001;女性:40.1±4.6 vs 21.7±2.9 ng/ml,p<0.01;男性:27.9±5.7 vs 10.9±2.3 ng/ml;p<0.05),空腹胰岛素水平(178±30 vs 81±10 pmol/l;p<0.01)和C肽水平(1.51±0.12 vs 0.77±0.07 nmol/l;p<0.001)亦是如此。在12例患者的亚组中,与肥胖对照组相比,躯干脂肪量显著升高(19.2 kg vs 14.7 kg,p<0.01,躯干身体组织百分比为42% vs 36%,p<0.05),而总脂肪量增加不显著。CS患者血清瘦素与全身脂肪百分比呈正相关(r=0.94,p<0.001),对照组亦是如此(r=0.68,p<0.01)。两组中瘦素与躯干身体脂肪百分比的相关性也很显著(CS组:r=0.84,p<0.001;对照组:r=0.63,p<0.01)。多元回归分析显示,全身脂肪百分比是CS患者瘦素浓度的预测指标(r2=0.88,p<0.001),而胰岛素对瘦素浓度的变化无显著贡献。在对照组中,瘦素和胰岛素(r2=0.65,p<0.001)均对瘦素水平的变化有显著贡献。在内源性CS患者中,校正全身脂肪差异后,与BMI匹配的肥胖对照组相比,血清瘦素水平显著升高。这表明CS患者的高瘦素血症并非主要反映身体成分的变化,而是不同激素对脂肪组织影响的结果。